Advancis Pharmaceutical to Present at Rodman and Renshaw 8th Annual Healthcare Conference
2006年11月2日 - 11:20PM
PRニュース・ワイアー (英語)
Presentation Will Be Webcast Live and Archived on Company's Web
Site GERMANTOWN, Md., Nov. 2 /PRNewswire-FirstCall/ -- Advancis
Pharmaceutical Corporation (NASDAQ:AVNC), a pharmaceutical company
focused on developing and commercializing novel anti-infective
products, today announced that Dr. Edward M. Rudnic, Advancis
president and CEO, will deliver a corporate presentation on Monday,
November 6, 2006, at 3:30 p.m. Eastern Time. The presentation will
take place as part of the Rodman and Renshaw 8th Annual Healthcare
Conference at the New York Palace Hotel in New York, New York. Dr.
Rudnic's remarks will be available live on the Advancis web site,
where they also will be archived for 30 days. To access the
presentation, log on to http://www.advancispharm.com/ and click on
the Presentations option in the Investor Relations section. Please
connect to the web site several minutes prior to the start of the
live presentation to ensure adequate time for any software download
that may be necessary. About Advancis Pharmaceutical: Advancis
Pharmaceutical Corporation (NASDAQ:AVNC) is a pharmaceutical
company focused on the development and commercialization of
anti-infective drug products that fulfill substantial unmet medical
needs in the treatment of infectious disease. The Company is
developing anti-infective drugs based on its novel biological
finding that bacteria exposed to antibiotics in front- loaded
staccato bursts, or "pulses," are killed more efficiently and
effectively than those under standard treatment regimens. Based on
this finding, Advancis has developed a proprietary, once-a-day
pulsatile delivery technology called PULSYS. By examining the
resistance patterns of bacteria and applying its delivery
technologies, Advancis has the potential to redefine infectious
disease therapy and significantly improve drug efficacy, shorten
length of therapy, and reduce drug resistance versus currently
available antibacterial products. For more on Advancis, please
visit http://www.advancispharm.com/. DATASOURCE: Advancis
Pharmaceutical Corporation CONTACT: Robert Bannon, Vice President,
Investor Relations and Corporate Communications of Advancis
Pharmaceutical Corporation, +1-301-944-6710, Web site:
http://www.advancispharm.com/
Copyright
Advancis (NASDAQ:AVNC)
過去 株価チャート
から 5 2024 まで 6 2024
Advancis (NASDAQ:AVNC)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Advancis Pharmaceutical (MM) (ナスダック市場): 0 recent articles
その他のAdvancis Pharmaceutical (MM)ニュース記事